Grant: Project Grant
Montreal Heart Institute
$921,826.00
Role of the Calcitonin Receptor System in Cardiac Physiology and Remodeling
FY 2021-22
Summary
The health problem that we will be studying is cardiac remodeling. In response to heart disease, the properties of the heart adapt, a process called "remodeling". Remodeling can be beneficial, but when excessive or prolonged it can be harmful. In response to disease or stress, the heart tends to remodel in an initially adaptive fashion, but like in many situations, there "is no free lunch" and when the stress is prolonged, remodeling causes serious adverse consequences that cause heart function to deteriorate. The ways in which the heart remodels are important determinants of the outcome of heart disease and many clinically effective treatments have been discovered through their beneficial effects on heart remodeling in animal models of human disease. We have found that a hormone called calcitonin, previously unknown to be active in the heart (but an important product of the thyroid gland), can be produced in the heart and protect against adverse cardiac remodeling. We have discovered that, in mice, when the receptors through which calcitonin acts called ("calcitonin receptors") are knocked out, the animals show enhanced adverse remodeling in response to the kinds of stress situations that cause human heart disease. This observation suggest that signalling through the calcitonin receptor occurs in the heart and protects the heart against adverse remodeling In this project, we aim to find out how calcitonin-receptors produce their protective actions in heart disease and how this knowledge might be used to prevent or treat the development of heart disease in man.
Department
Program
Project Grant
Recipient
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
460085
Name
Nattel Stanley
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Cardiovascular System - B: Heart and Circulation
Projecttitle
Role of the Calcitonin Receptor System in Cardiac Physiology and Remodeling
Programtype2
Operating Grants
Orgnameinp2
Montreal Heart Institute
Cihramount2
$921,826
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cardiac Fibroblasts; Cardiomyocytes; Electrophysiology; Heart Failure; Pharmacology; Remodelling
Abstract
The health problem that we will be studying is cardiac remodeling. In response to heart disease, the properties of the heart adapt, a process called "remodeling". Remodeling can be beneficial, but when excessive or prolonged it can be harmful. In response to disease or stress, the heart tends to remodel in an initially adaptive fashion, but like in many situations, there "is no free lunch" and when the stress is prolonged, remodeling causes serious adverse consequences that cause heart function to deteriorate. The ways in which the heart remodels are important determinants of the outcome of heart disease and many clinically effective treatments have been discovered through their beneficial effects on heart remodeling in animal models of human disease. We have found that a hormone called calcitonin, previously unknown to be active in the heart (but an important product of the thyroid gland), can be produced in the heart and protect against adverse cardiac remodeling. We have discovered that, in mice, when the receptors through which calcitonin acts called ("calcitonin receptors") are knocked out, the animals show enhanced adverse remodeling in response to the kinds of stress situations that cause human heart disease. This observation suggest that signalling through the calcitonin receptor occurs in the heart and protects the heart against adverse remodeling In this project, we aim to find out how calcitonin-receptors produce their protective actions in heart disease and how this knowledge might be used to prevent or treat the development of heart disease in man.
Competitiondate
202203
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Nattel, Stanley
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $921,826~ $0~